FILTER

Refine your search with the following facets to narrow down your results.

7,529 Current news from the ressort business & finance

One Nucleus signs agreement with Bionow to expand access to One Nucleus preferred suppliers

06-Jan-2011 - One Nucleus announced that an agreement has been signed with Bionow for their Premium Members to have access to the One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. This agreement took effect on 1 January 2011. The One Nucleus Purchasing Consortium has an ...

Biogen Idec and Neurimmune Announce Agreement on Three Neurodegenerative Disease Programs

04-Jan-2011 - Biogen Idec and Neurimmune Holding AG announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three ...

Merck KGaA to Sell its Crop BioScience Business To Novozymes for USD 275 Million

04-Jan-2011 - Merck KGaA announced that it will sell its Crop BioScience business, which is part of the Performance Materials division, to Novozymes A/S, Denmark for a total consideration of USD 275 million. The agreement is subject to customary regulatory approvals. Closing of the transaction is expected in ...

EpiTherapeutics and Abbott Enter Into Oncology Collaboration on Epigenetic Targets

03-Jan-2011 - EpiTherapeutics and Abbott announced a collaboration agreement to develop new anti-cancer drugs by making small-molecule inhibitors against selected epigenetic oncology targets. Under the terms of the agreement EpiTherapeutics receives an up-front payment and will receive funding of research ...

BASF Plant Science and Bayer CropScience collaborate to develop higher-yielding hybrid rice

03-Jan-2011 - BASF Plant Science and Bayer CropScience announced a long-term collaboration agreement to improve rice productivity through plant biotechnology. The companies aim to develop and commercialize hybrid rice seeds with traits enabling yield advances of 10 percent or more over conventional hybrid rice ...

Phylogica Signs Collaboration and Licensing Deal with Pfizer

03-Jan-2011 - Phylogica Ltd, a public Australian drug discovery company, announced that it has entered into a collaboration and licensing agreement with Pfizer to discover novel peptide-based vaccines. Phylogica will employ its proprietary Phylomer® drug discovery platform to identify Phylomer peptides ...

Biogemma and Wageningen UR announce a collaboration in wheat drought tolerance research

31-Dec-2010 - Due to climate change and ever more limiting resources, the development of more stress resistant crops to cope with changing conditions is an important research topic for many R&D groups and Ag-Seed companies. Biogemma CEO Pascual Perez explains: “Creating innovative GM and non GM trait ...

drought tolerance genomics plant breeding

Swedish Orphan Biovitrum returns development rights to Sym001 to Symphogen

30-Dec-2010 - Swedish Orphan Biovitrum announced that it has returned full development rights to Symphogen, co-developer of Sym001, for ITP (Immune Thrombocytopenic Purpura) treatment and for HDN (Hemolytic Disease in Newborn) prophylaxis, for strategic reasons. Sym001 is currently in clinical phase II for ...

Swedish Orphan Biovitrum

New Stem Cell Company Launched to Benefit Human and Veterinary Patients

29-Dec-2010 - A new collaboration between a human clinical cell processing facility and tissue bank (General BioTechnology, LLC) and clinical experts in hematology/oncology, oral surgery and veterinary medicine has been launched. RenovoCyte, LLC is a cellular medicine company that is dedicated to the use of ...

cell therapy

DSM to form global anti-infectives joint venture with Sinochem Group

28-Dec-2010 - Royal DSM N.V. announced that it has reached an agreement with Sinochem Group to form a 50/50 global joint venture for its business group DSM Anti-Infectives. The transaction is subject to receipt of regulatory approvals (including approvals from regulatory authorities in China) and customary ...

anti-infectives DSM joint ventures